34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03688568 (ClinicalTrials.gov)	September 1, 2018	11/9/2018	Study of Imatinib in Children With Neurofibromatosis and Airway Tumors	Phase 2 Study of Imatinib in Children With Neurofibromatosis and Airway Tumors	Neurofibroma, Plexiform	Drug: Imatinib Mesylate	Indiana University	NULL	Withdrawn	6 Months	12 Years	All	0	Phase 2	United States
2	NCT02177825 (ClinicalTrials.gov)	June 2014	25/6/2014	Study of ImatinibMesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibr ...	Phase II Study of ImatinibMesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform ...	Plexiform Neurofibromas	Drug: Imatinib Mesylate	St. Justine's Hospital	NULL	Terminated	2 Years	21 Years	All	5	Phase 2	Canada
3	EUCTR2009-016922-15-ES (EUCTR)	04/02/2010	19/11/2009	ENSAYO PILOTO CON IMATINIBPARA PACIENTES CON NEUROFIBROMA PLEXIFORME ASOCIADO A LA NEUROFIBROMATOSIS ...	ENSAYO PILOTO CON IMATINIBPARA PACIENTES CON NEUROFIBROMA PLEXIFORME ASOCIADO A LA NEUROFIBROMATOSIS ...	Tratamiento de los neurofibromas plexiformes de alto riesgo no abordables quirúrgicamente en pacient ...	Trade Name: GLIVEC 100 mg comprimidos recubiertos con película INN or Proposed INN: IMATINIB Other des ...	HOSPITAL SANT JOAN DE DÉU	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Spain

First Previous1Next Last